A trial for improving oxidative stress in tear fluid A randomized double-blind placebo-controlled parallel-group study - A trial for improving oxidative stress in tear fluid

ORTHOMEDICO Inc.0 个研究点目标入组 30 人开始时间: 2014年7月18日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•a)Persons who have previous medical history of malignant tumor or heart failure or myocardial infarction b)Patients being treated for at least one of following diseases atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder,cerebrovascular disorder, rheumatism,diabetes mellitus, dyslipidemia,hypertension and other chronic disease c)Persons who have ophthalmopathy or entropion or trichiasis d)Persons who have ametropia and don`t be treated orthoptics properly e)Persons who are strong astigmatism f)Persons who are achromatopsia g)Persons who were treated with LASIK h)Persons who have cause of eyestrain except for neurological deficit,et al. or regulatory function i)Persons who take medicines, herbal medicines j)Persons who are allergic to medicines, or products related to the test material of this trial k)Pregnant women, lactating women, or women who want to get pregnant during the trial period l)Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial m)Persons who are judged not suitable to participate in this trial by physician

发起方